Retrieved from Trenson, L., Trenson, S., van Nes, F., et al
Quick Answer: Zepbound carries an FDA warning for acute pancreatitis, though clinical evidence suggests any absolute risk increase appears small and causality remains uncertain
GLP-1 medications have demonstrated cardioprotective effects in type 2 diabetes, and while data in type 1 diabetes are limited, the potential is promising
If genetic testing shows you're a rapid metabolizer, your provider might recommend more frequent dosing or higher concentrations to maintain steady therapeutic levels
The authors emphasize that exercises value extends far beyond energy balance it has important complementary effects, including improved insulin sensitivity, increased fat oxidation and, perhaps most importantly, preservation of fat-free mass